186 related articles for article (PubMed ID: 14507652)
1. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
Nielsen TO; Hsu FD; O'Connell JX; Gilks CB; Sorensen PH; Linn S; West RB; Liu CL; Botstein D; Brown PO; van de Rijn M
Am J Pathol; 2003 Oct; 163(4):1449-56. PubMed ID: 14507652
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants.
Subramaniam MM; Navarro S; Pellin A; López-Guerrero JA; Carda C; Heredia Alvaro JA; Gozalbo Sabater PL; Llombart-Bosch A
Virchows Arch; 2006 Oct; 449(4):435-47. PubMed ID: 16957934
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
4. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
5. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB
Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
[TBL] [Abstract][Full Text] [Related]
8. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
9. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
[TBL] [Abstract][Full Text] [Related]
10. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
11. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma.
Olsen SH; Thomas DG; Lucas DR
Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
13. [Expression of TEIF protein in soft tissue tumors and its significance].
Gong YL; Li T; Guo H; Sun Y; Chi YK; Ling Y; Shen Q; Liu HJ; Hou L; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):651-5. PubMed ID: 17374207
[TBL] [Abstract][Full Text] [Related]
14. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
Zayed H; Petersen I
Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
[TBL] [Abstract][Full Text] [Related]
16. Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins.
Miettinen M
Am J Pathol; 1991 Feb; 138(2):505-13. PubMed ID: 1704194
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling.
Lee YF; John M; Edwards S; Clark J; Flohr P; Maillard K; Edema M; Baker L; Mangham DC; Grimer R; Wooster R; Thomas JM; Fisher C; Judson I; Cooper CS
Br J Cancer; 2003 Feb; 88(4):510-5. PubMed ID: 12592363
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.
Chuang HC; Hsu SC; Huang CG; Hsueh S; Ng KF; Chen TC
Pathol Int; 2013 Dec; 63(12):573-80. PubMed ID: 24422953
[TBL] [Abstract][Full Text] [Related]
19. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
